Explore recent insider activity at Aquestive Therapeutics (NYSE:AQST), ownership trends, and what they may indicate about the company's long-term outlook, corporate alignment, and market sentiment.
Zacks Investment Research on MSN
Aquestive Therapeutics (AQST) moves 6.6% higher: Will this strength last?
Aquestive Therapeutics (AQST) shares rallied 6.6% in the last trading session to close at $5.03. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
NEW YORK, March 31, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Aquestive Therapeutics, Inc. (NASDAQ: AQST). Shareholders who purchased shares of AQST during ...
Zacks.com on MSN
Medifast (MED) Loses 18.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
A downtrend has been apparent in Medifast (MED) lately with too much selling pressure. The stock has declined 18.9% over the past four weeks. However, given the fact that it is now in oversold ...
The average one-year price target for Aquestive Therapeutics (NasdaqGM:AQST) has been revised to $10.51 / share. This is an increase of 14.80% from the prior estimate of $9.15 dated November 7, 2025.
Aquestive Therapeutics Inc. Annual stock financials by MarketWatch. View the latest AQST financial statements, income statements and financial ratios.
NEW YORK, April 7, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Aquestive Therapeutics, Inc. (NASDAQ: AQST). Shareholders who purchased shares of AQST during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results